Headache Disorders, Primary: Clinical Trials

1,744 trials for Headache Disorders, Primary, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1037 completed, 238 unknown, 158 recruiting, 106 terminated. 663 Not applicable, 272 Phase 3, 199 Phase 2, 173 Phase 4, 109 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable663Completed 369, Unknown 100, Recruiting 67, Terminated 40, Not yet recruiting 37, Withdrawn 19, Active not recruiting 18, Enrolling by invitation 9, Suspended 4
Phase 3272Completed 200, Recruiting 17, Unknown 17, Terminated 14, Withdrawn 13, Active not recruiting 4, Enrolling by invitation 3, Not yet recruiting 3, Suspended 1
Phase 2199Completed 129, Terminated 23, Unknown 18, Recruiting 14, Withdrawn 6, Not yet recruiting 5, Enrolling by invitation 2, Active not recruiting 1, Suspended 1
Phase 4173Completed 107, Unknown 21, Terminated 15, Recruiting 12, Not yet recruiting 6, Withdrawn 6, Active not recruiting 4, Enrolling by invitation 1, Suspended 1
Phase 1109Completed 82, Unknown 9, Terminated 8, Withdrawn 4, Enrolling by invitation 2, Not yet recruiting 2, Recruiting 2
Early Phase 18Completed 5, Recruiting 2, Unknown 1

Follow Headache Disorders, Primary: new trials by email Literature Review of Headache Disorders, Primary trials Research Report on Headache Disorders, Primary

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Observational Study to Assess Migraine Prediction Tool
Daily questionnaire - Migraine
SuspendedTheranica2002030-01-012024-11-22
EMBRACE Study: Enduring Migraine Benefit From Responsive Artery Coil Embolization
TEMMA Endovascular Treatment - Migraine Disorders, Refractory Migraine
Not applicableWithdrawnCortex Neurovascular2028-03-012026-10-27
Calcitonin Gene-related Peptide Antibody in Acute Mountain Sickness
Fremanezumab 225 Mg/1.5 mL Subcutaneous Solution, Placebo - Acute Mountain Sickness
Phase 4Not yet recruitingInsel Gruppe AG, University Hospital Bern302027-06-012026-07-01
Nortriptyline Compared With Amitriptyline for Migraine Prevention at SQUH
Nortriptyline, Amitriptyline - Migraine
Phase 4Not yet recruitingSultan Qaboos University902027-05-012026-10-02
A Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus)
Glycerol Tributyrate - MELAS Syndrome, Lebers Hereditory Optic Neuropathy With Extra Ocular Symptoms (LHON-Plus)
Phase 1 / Phase 2Not yet recruitingGeorge Washington University242027-03-012026-10-05
Multimodal Therapy for Somatosensory Tinnitus
Multimodal physiotherapy for TMJ and Cervical spine, Combined Exercise Program (Aerobic + Resistance + Breathing), Tinnitus-Specific Psychological Support - Ear Noise, Tinnitus, Noise Induced
Not applicableNot yet recruitingCharles University, Czech Republic1602027-01-012026-03-12
Effect of Atogepant on the Vestibulo-Ocular Reflex in Healthy Adults and Adults With Migraine
Atogepant 60 mg, Placebo - Migraine Disorders, Brain, Healthy Adult Participants
Phase 4Not yet recruitingKonrad Peter Weber802027-01-012026-09-17
A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine
Neurostimulator - Resistant Migraine, Chronic Migraine Headache
Not applicableRecruitingSalvia BioElectronics1502026-12-012026-08-28
Efficacy, Safety and Tolerability of Low Sodium Oxybate for Nocturnal Cluster Headache Attacks
Low Sodium Oxybate, Placebo - Chronic Cluster Headache
Phase 2Not yet recruitingLeiden University Medical Center522026-12-012026-08-25
Sequential, Multiple Assignment, Double Randomized Preference, Migraine Behavioral Trial
Migraine Behavioral Treatment - Migraine, Headache
Not applicableNot yet recruitingMayo Clinic242026-12-012026-06-16
Assessment of Head Awareness in Patients With Migraine in the Greek Population
Migraine
Not yet recruitingNational and Kapodistrian University of Athens902026-11-012026-10-08
Validity and Reliability of the Greek WPAI:Migraine
Migraine
Not yet recruitingNational and Kapodistrian University of Athens602026-11-012026-10-08
Validity and Reliability of the Greek Pain Catastrophizing Scale
Migraine
Not yet recruitingNational and Kapodistrian University of Athens1302026-11-012026-10-07
Headache and Hormone Use Among Transgender Population in Thailand: A Cross-Sectional Online Study
gender-affirming hormone therapy, Gender-Affirming Surgery, HIV Pre-Exposure Prophylaxis - Headache, Migraine
Not yet recruitingChulalongkorn University5002026-11-012026-09-14
Eary Infusion of Eptinezumab for TreatmEnt of ACute Post-Traumatic Headaches (ELITE-ACT)
Eptinezumab, Placebo - Post Traumatic Headache
Phase 3RecruitingSunnybrook Health Sciences Centre802026-11-012026-10-29
Migraine Headaches Elimination With Patent Foramen Ovale-Directed Therapy
Prasugrel 5mg, Transcatheter Closure of Patent Foramen Ovale - Migraine Disease, Patent Foramen Ovale
Phase 3RecruitingColumbia University322026-10-152026-10-08
Efficacy of Rimegepant 75 mg for the Acute Treatment of Migraine: a Bayesian Individual Participant Data Meta-analysis Standardized to Defined Target Populations
Rimegepant, Placebo - Migraine
Active not recruitingPfizer12026-10-122026-10-30
Low-Intensity Focused Ultrasound Targeting the Dorsolateral Prefrontal Cortex for Preventive Treatment of Chronic Migraine
Low-Intensity Focused Ultrasound Stimulation, Sham Low-Intensity Focused Ultrasound Stimulation - Chronic Migraine Headache
Not applicableNot yet recruitingChinese PLA General Hospital362026-10-082026-10-05
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Elismetrep, Placebo - Migraine
Phase 3RecruitingTriGemX Bio, Inc.15002026-10-022026-11-02
Neuromodulation During the Prodrome to Prevent Disabling Migraine Attacks in Youth
Active Remote Electrical Neuromodulation, Sham Remote Electrical Neuromodulation - Migraine, Migraine Headache
Not applicableNot yet recruitingUniversity of Calgary302026-10-012026-08-19

Showing 20 of 1744. Sign in to see all of them.

Narrower conditions

Migraine Disorders (1486)  ·  Headache (341)  ·  Tension-Type Headache (131)  ·  Cluster Headache (122)  ·  Migraine with Aura (114)  ·  Migraine without Aura (109)  ·  Pain (94)  ·  Headache Disorders (65)  ·  Epilepsy (42)  ·  Chronic Pain (26)  ·  Foramen Ovale, Patent (26)  ·  Depression (24)  ·  Emergencies (24)  ·  Anxiety Disorders (22)

Broader conditions

Central Nervous System Diseases (1736)  ·  Nervous System Diseases (1735)  ·  Brain Diseases (1732)  ·  Headache Disorders (1679)  ·  Pathological Conditions, Signs and Symptoms (535)  ·  Signs and Symptoms (498)  ·  Neurologic Manifestations (481)  ·  Pain (348)  ·  Trigeminal Autonomic Cephalalgias (111)  ·  Pathologic Processes (77)  ·  Behavior (67)  ·  Mental Disorders (64)  ·  Migraine Disorders (64)  ·  Cardiovascular Diseases (61)

Interventions

Sumatriptan (69)  ·  Topiramate (56)  ·  erenumab (51)  ·  rimegepant sulfate (42)  ·  Sodium Chloride (39)  ·  Botulinum Toxins, Type A (36)  ·  Naproxen (31)  ·  eptinezumab (28)  ·  fremanezumab (25)  ·  rizatriptan (25)  ·  Saline Solution (24)  ·  Metoclopramide (23)  ·  galcanezumab (23)  ·  atogepant (19)  ·  Acetaminophen (17)

Sponsors

Danish Headache Center (84)  ·  Pfizer (43)  ·  Eli Lilly and Company (33)  ·  GlaxoSmithKline (30)  ·  Allergan (25)  ·  Amgen (22)  ·  AbbVie (20)  ·  Theranica (20)  ·  IRCCS National Neurological Institute "C. Mondino" Foundation (19)  ·  Merck Sharp & Dohme LLC (18)  ·  Thomas Jefferson University (18)  ·  H. Lundbeck A/S (17)  ·  Mayo Clinic (17)  ·  Montefiore Medical Center (16)  ·  Organon and Co (14)

Countries

United States (683)  ·  Denmark (135)  ·  Italy (116)  ·  Spain (104)  ·  Turkey (Türkiye) (103)  ·  Germany (93)  ·  Canada (81)  ·  France (81)  ·  China (75)  ·  United Kingdom (75)  ·  Belgium (55)  ·  Israel (43)  ·  Poland (42)  ·  Netherlands (40)  ·  Norway (40)

Top investigators

Roger K Cady, MD (9)  ·  Alit Stark Inbar, PhD (7)  ·  Mia Minen, MD (6)

Results publications

PMID 11914403, PMID 12807523, PMID 8984084, PMID 39982105, PMID 31482569, PMID 32576229, PMID 33781209, PMID 17405970, PMID 31952501, PMID 34823467, PMID 35978286, PMID 37965170, PMID 11284464, PMID 25500317, PMID 30496104, PMID 31291516, PMID 33142014, PMID 34264500, PMID 34874514, PMID 34928306, PMID 35076090, PMID 36125279, PMID 36739511, PMID 37303034, PMID 38462625, PMID 39648629, PMID 41235617, PMID 41652666, PMID 42839212, PMID 11112243, PMID 16135345, PMID 17175134, PMID 17955107, PMID 18662331, PMID 19453963, PMID 19486178, PMID 19546766, PMID 20353434, PMID 20487038, PMID 20548058, PMID 20647241, PMID 20855373, PMID 21521204, PMID 21883197, PMID 22520687, PMID 22590713, PMID 23567060, PMID 23731663, PMID 24524844, PMID 24579886

NIH funding

2019 (16), 2018 (9), 2023 (9), 2015 (8), 2016 (8), 2008 (4), 2014 (4), 2017 (3), 2025 (2), K01NS124911 (2), R01AT011005 (2), UL1TR001082 (2), 1UG3AT013498-01 (1), 2004 (1), 2005 (1)